Valeant Inks $1B Deal For Female Libido Drugmaker Sprout
Valeant Pharmaceuticals International Inc. will shell out $1 billion in cash for Sprout Pharmaceuticals Inc., snapping up the drugmaker that recently gained approval for its female libido pill, the two companies...To view the full article, register now.
Already a subscriber? Click here to view full article